In vitro activity of trovafloxacin against Chlamydia pneumoniae.

The in vitro susceptibilities of 12 strains of Chlamydia pneumoniae to a new quinolone, trovafloxacin, and ofloxacin, doxycycline, erythromycin, and azithromycin were determined. The activity of trovafloxacin was similar to that of ofloxacin, with a MIC at which 90% of the isolates are inhibited and...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Roblin, P M, Kutlin, A, Hammerschlag, M R
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1997
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164061/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9303410/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.9.2033
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!